vs
CoreCivic, Inc.（CXW）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是CoreCivic, Inc.的1.2倍（$702.9M vs $604.0M），Healthpeak Properties净利率更高（51.6% vs 4.4%，领先47.2%），CoreCivic, Inc.同比增速更快（26.0% vs -6.6%），过去两年CoreCivic, Inc.的营收复合增速更高（9.8% vs 0.5%）
CoreCivic, Inc.是美国私营监狱运营企业，为美国规模最大的营利性监狱、看守所及拘留设施承包商之一。该公司在美国运营70余座州级及联邦惩教、拘留场所，曾因相关场所被指存在民权侵犯、强迫劳动问题，成为撤资运动针对对象，还遭到FBI调查及多起诉讼。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CXW vs DOC — 直观对比
营收规模更大
DOC
是对方的1.2倍
$604.0M
营收增速更快
CXW
高出32.7%
-6.6%
净利率更高
DOC
高出47.2%
4.4%
两年增速更快
CXW
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $604.0M | $702.9M |
| 净利润 | $26.5M | $363.0M |
| 毛利率 | — | — |
| 营业利润率 | 6.0% | 0.7% |
| 净利率 | 4.4% | 51.6% |
| 营收同比 | 26.0% | -6.6% |
| 净利润同比 | 37.7% | 28.3% |
| 每股收益（稀释后） | $0.26 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CXWDOC
| Q1 26 | — | $702.9M | ||
| Q4 25 | $604.0M | $719.4M | ||
| Q3 25 | $580.4M | $705.9M | ||
| Q2 25 | $538.2M | $694.3M | ||
| Q1 25 | $488.6M | $702.9M | ||
| Q4 24 | $479.3M | $698.0M | ||
| Q3 24 | $491.6M | $700.4M | ||
| Q2 24 | $490.1M | $695.5M |
净利润CXWDOC
| Q1 26 | — | $363.0M | ||
| Q4 25 | $26.5M | $114.0M | ||
| Q3 25 | $26.3M | $-117.1M | ||
| Q2 25 | $38.5M | $31.7M | ||
| Q1 25 | $25.1M | $42.8M | ||
| Q4 24 | $19.3M | $4.5M | ||
| Q3 24 | $21.1M | $85.9M | ||
| Q2 24 | $19.0M | $146.0M |
毛利率CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 61.1% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | — | 60.6% |
营业利润率CXWDOC
| Q1 26 | — | 0.7% | ||
| Q4 25 | 6.0% | 17.4% | ||
| Q3 25 | 6.3% | 9.2% | ||
| Q2 25 | 9.7% | 5.7% | ||
| Q1 25 | 6.6% | 7.7% | ||
| Q4 24 | 5.2% | -2.2% | ||
| Q3 24 | 6.1% | 14.1% | ||
| Q2 24 | 5.6% | 22.3% |
净利率CXWDOC
| Q1 26 | — | 51.6% | ||
| Q4 25 | 4.4% | 73.2% | ||
| Q3 25 | 4.5% | -16.6% | ||
| Q2 25 | 7.2% | 4.6% | ||
| Q1 25 | 5.1% | 6.1% | ||
| Q4 24 | 4.0% | 0.7% | ||
| Q3 24 | 4.3% | 12.3% | ||
| Q2 24 | 3.9% | 21.0% |
每股收益（稀释后）CXWDOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | $0.26 | $0.16 | ||
| Q3 25 | $0.24 | $-0.17 | ||
| Q2 25 | $0.35 | $0.05 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.18 | $0.02 | ||
| Q3 24 | $0.19 | $0.12 | ||
| Q2 24 | $0.17 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.9M | $-1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $7.8B |
| 总资产 | $3.3B | $21.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CXWDOC
| Q1 26 | — | $-1.2B | ||
| Q4 25 | $97.9M | $467.5M | ||
| Q3 25 | $56.6M | $91.0M | ||
| Q2 25 | $130.5M | $89.4M | ||
| Q1 25 | $74.5M | $70.6M | ||
| Q4 24 | $107.5M | $119.8M | ||
| Q3 24 | $107.8M | $180.4M | ||
| Q2 24 | $60.2M | $106.9M |
总债务CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益CXWDOC
| Q1 26 | — | $7.8B | ||
| Q4 25 | $1.4B | $7.5B | ||
| Q3 25 | $1.5B | $7.6B | ||
| Q2 25 | $1.5B | $7.9B | ||
| Q1 25 | $1.5B | $8.2B | ||
| Q4 24 | $1.5B | $8.4B | ||
| Q3 24 | $1.5B | $8.6B | ||
| Q2 24 | $1.4B | $8.8B |
总资产CXWDOC
| Q1 26 | — | $21.6B | ||
| Q4 25 | $3.3B | $20.3B | ||
| Q3 25 | $3.1B | $19.6B | ||
| Q2 25 | $3.1B | $19.8B | ||
| Q1 25 | $3.0B | $19.8B | ||
| Q4 24 | $2.9B | $19.9B | ||
| Q3 24 | $2.9B | $20.0B | ||
| Q2 24 | $2.9B | $20.2B |
负债/权益比CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-376.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-45.1M | — |
| 自由现金流率自由现金流/营收 | -7.5% | — |
| 资本支出强度资本支出/营收 | 7.4% | 3.4% |
| 现金转化率经营现金流/净利润 | -0.01× | — |
| 过去12个月自由现金流最近4个季度 | $52.8M | — |
8季度趋势，按日历期对齐
经营现金流CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | $-376.0K | $1.3B | ||
| Q3 25 | $53.8M | $315.0M | ||
| Q2 25 | $96.7M | $363.5M | ||
| Q1 25 | $44.5M | $279.4M | ||
| Q4 24 | $39.3M | $1.1B | ||
| Q3 24 | $91.5M | $318.2M | ||
| Q2 24 | $68.1M | $316.2M |
自由现金流CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | $-45.1M | $357.0M | ||
| Q3 25 | $16.1M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $20.0M | — | ||
| Q4 24 | $16.0M | $333.7M | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $49.3M | — |
自由现金流率CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | -7.5% | 49.6% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 3.3% | 47.8% | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 10.1% | — |
资本支出强度CXWDOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | 7.4% | 124.4% | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 4.9% | 105.6% | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 3.8% | — |
现金转化率CXWDOC
| Q1 26 | — | — | ||
| Q4 25 | -0.01× | 10.99× | ||
| Q3 25 | 2.04× | — | ||
| Q2 25 | 2.51× | 11.48× | ||
| Q1 25 | 1.77× | 6.52× | ||
| Q4 24 | 2.04× | 235.43× | ||
| Q3 24 | 4.34× | 3.71× | ||
| Q2 24 | 3.59× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CXW
暂无分部数据
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
